Atossa Genetics
Price & Volume
Stats
See more52W Range | $0.72-$2.31 |
Market Cap | $108.8M |
Shares Short | 8M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.21 |
News
See moreYahoo Finance • yesterday
Atossa Therapeutics Responds to PTAB Ruling on U.S. Patent No. 11,572,334 and Announces the Issuance of U.S. Patent No. 12,201,591
Yahoo Finance • 8 days ago
Atossa Therapeutics Issues Letter to Shareholders Highlighting 2024 Accomplishments and Outlook for 2025
Yahoo Finance • last year
Atossa Therapeutics Announces Full Enrollment of Phase 2 Karisma-Endoxifen Clinical Trial
Yahoo Finance • last year
Atossa Therapeutics Announces Third Quarter 2023 Financial Results and Provides Corporate Update
About
CEO | Dr. Steven C. Quay FCAP, M.D., Ph.D. |
Address | 107 Spring Street, Seattle, WA, United States, 98104 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 12 |
